Promising Advances in LINC01116 Related to Cancer

Long non-coding RNAs (lncRNAs) are RNAs with a length of no less than 200 nucleotides that are not translated into proteins. Accumulating evidence indicates that lncRNAs are pivotal regulators of biological processes in several diseases, particularly in several malignant tumors. Long intergenic non-protein coding RNA 1116 (LINC01116) is a lncRNA, whose aberrant expression is correlated with a variety of cancers, including lung cancer, gastric cancer, colorectal cancer, glioma, and osteosarcoma. LINC01116 plays a crucial role in facilitating cell proliferation, invasion, migration, and apoptosis. In addition, numerous studies have recently suggested that LINC01116 has emerged as a novel biomarker for prognosis and therapy in malignant tumors. Consequently, we summarize the clinical significance of LINC01116 associated with biological processes in various tumors and provide a hopeful orientation to guide clinical treatment of various cancers in future studies.

[1]  J. Grinband,et al.  BOLD Asynchrony Elucidates Tumor Burden in IDH-Mutated Gliomas. , 2021, Neuro-oncology.

[2]  R. Reiter,et al.  Melatonin inhibits lung cancer development by reversing the Warburg effect via stimulating the SIRT3/PDH axis , 2021, Journal of pineal research.

[3]  Swati G. Patel,et al.  Characteristics of Early-Onset vs Late-Onset Colorectal Cancer: A Review. , 2021, JAMA surgery.

[4]  Dechen Liu,et al.  The long non-coding RNA βFaar regulates islet β-cell function and survival during obesity in mice , 2021, Nature Communications.

[5]  Z. Zeng,et al.  Long non-coding RNA AFAP1-AS1 accelerates lung cancer cells migration and invasion by interacting with SNIP1 to upregulate c-Myc , 2021, Signal Transduction and Targeted Therapy.

[6]  Rakesh Kumar,et al.  Role of Epigenetics in carcinogenesis: Recent Advancements in Anticancer Therapy. , 2021, Seminars in cancer biology.

[7]  Chen Wu,et al.  LINC00842 inactivates transcription co-regulator PGC-1α to promote pancreatic cancer malignancy through metabolic remodelling , 2021, Nature Communications.

[8]  Liang Chang,et al.  Long non-coding RNA LINC01116 is activated by EGR1 and facilitates lung adenocarcinoma oncogenicity via targeting miR-744-5p/CDCA4 axis , 2021, Cancer cell international.

[9]  R. Yue,et al.  A functional motif of long noncoding RNA Nron against osteoporosis , 2021, Nature Communications.

[10]  Zhen Feng,et al.  Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway , 2021, Thoracic cancer.

[11]  A. Kotani,et al.  Non-coding RNAs and lipids mediate the function of extracellular vesicles in cancer cross-talk. , 2021, Seminars in cancer biology.

[12]  Yuting He,et al.  FENDRR: A pivotal, cancer-related, long non-coding RNA. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  Yuting He,et al.  Promising role of long non-coding RNA PCAT6 in malignancies. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  H. Yoshida,et al.  Long noncoding RNA‐dependent methylation of nonhistone proteins , 2021, Wiley interdisciplinary reviews. RNA.

[15]  Wei Yang,et al.  Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma , 2021, Journal of translational medicine.

[16]  Y. Liao,et al.  Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation , 2021, Autophagy.

[17]  Hui-hong Yu,et al.  Long non-coding RNA LINC01116 acts as an oncogene in prostate cancer cells through regulation of miR-744-5p/UBE2L3 axis , 2021, Cancer cell international.

[18]  Dayu Liu,et al.  A pocket-sized device automates multiplexed point-of-care RNA testing for rapid screening of infectious pathogens. , 2021, Biosensors & bioelectronics.

[19]  Dekang Liu,et al.  Zi Shen Decoction Inhibits Growth and Metastasis of Lung Cancer via Regulating the AKT/GSK-3β/β-Catenin Pathway , 2021, Oxidative medicine and cellular longevity.

[20]  Butian Zhang,et al.  LINC01116 Promotes Doxorubicin Resistance in Osteosarcoma by Epigenetically Silencing miR-424-5p and Inducing Epithelial-Mesenchymal Transition , 2021, Frontiers in Pharmacology.

[21]  S. Corso,et al.  Microsatellite instability in Gastric Cancer: Between lights and shadows. , 2021, Cancer treatment reviews.

[22]  C. Hur,et al.  International cost-effectiveness analysis evaluating endoscopic screening for gastric cancer for populations with low and high risk , 2021, Gastric Cancer.

[23]  K. Miyazono,et al.  PRRX1 induced by BMP signaling decreases tumorigenesis by epigenetically regulating glioma‐initiating cell properties via DNA methyltransferase 3A , 2021, Molecular oncology.

[24]  L. Xian,et al.  LncRNA LINC01116 sponges miR-93-5p to promote cell invasion and migration in small cell lung cancer , 2021, BMC Pulmonary Medicine.

[25]  Jie Wu,et al.  LINC01116 facilitates colorectal cancer cell proliferation and angiogenesis through targeting EZH2-regulated TPM1 , 2021, Journal of translational medicine.

[26]  Qing Yang,et al.  LINC01116 promotes proliferation and migration of endometrial stromal cells by targeting FOXP1 via sponging miR‐9‐5p in endometriosis , 2020, Journal of cellular and molecular medicine.

[27]  Chuanxin Wang,et al.  Role of gut microbiota in epigenetic regulation of colorectal Cancer. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[28]  A. Goel,et al.  Non-coding RNAs and potential therapeutic targeting in cancer. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[29]  Wei Wei,et al.  Activation of nuclear factor‐κB in the angiogenesis of glioma: Insights into the associated molecular mechanisms and targeted therapies , 2020, Cell proliferation.

[30]  Xinhua Lin,et al.  Ultrasensitive Detection of RNA with Single-Base Resolution by Coupling Electrochemical Sensing Strategy with Chimeric DNA Probe-Aided Ligase Chain Reaction. , 2020, Analytical chemistry.

[31]  S. Guo,et al.  The pan-cancer lncRNA PLANE regulates an alternative splicing program to promote cancer pathogenesis , 2020, Nature Communications.

[32]  S. Markowitz,et al.  Epigenetic alterations in the gastrointestinal tract: Current and emerging use for biomarkers of cancer. , 2020, Gastroenterology.

[33]  Jinlan Jiang,et al.  Corrigendum to "LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway" [Biomed. Pharmacother. 107 (2018) 270-282]. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[34]  Zhaoxu Liu,et al.  LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression , 2020, Cell Death & Disease.

[35]  Mengyu Xie,et al.  EPB41 suppresses the Wnt/β-catenin signaling in non-small cell lung cancer by sponging ALDOC. , 2020, Cancer letters.

[36]  S. Maurya,et al.  Epigenetic Modifications of c-MYC: Role in Cancer Cell Reprogramming, Progression and Chemoresistance. , 2020, Seminars in cancer biology.

[37]  Zhijun Luo,et al.  The dichotomous role of TGF-β in controlling liver cancer cell survival and proliferation. , 2020, Journal of genetics and genomics = Yi chuan xue bao.

[38]  Yongjia Liu,et al.  Hydroxyapatite–Bovine Serum Albumin–Paclitaxel Nanoparticles for Locoregional Treatment of Osteosarcoma , 2020, Advanced healthcare materials.

[39]  W. Wu,et al.  An update on the roles of circular RNAs in osteosarcoma , 2020, Cell proliferation.

[40]  J. Fichna,et al.  New insights into molecular pathways in colorectal cancer: Adiponectin, interleukin-6 and opioid signaling. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[41]  J. Onnela,et al.  Can mHealth interventions improve quality of life of cancer patients? A systematic review and meta-analysis , 2020, Critical Reviews in Oncology/Hematology.

[42]  Jinming Li,et al.  Technologies for targeted DNA methylation modifications in cancer:Mechanism and application. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[43]  R. Kulshreshtha,et al.  Potential of microRNA based diagnostics and therapeutics in glioma: a patent review , 2020, Expert opinion on therapeutic patents.

[44]  H. Cui,et al.  LncRNA LINC01116 Promotes the Development of Colorectal Cancer by Targeting miR-9-5p/STMN1 , 2020, OncoTargets and therapy.

[45]  Zhaoxia Wang,et al.  LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma , 2020, OncoTargets and therapy.

[46]  Guangchao Sui,et al.  Human MYC G-quadruplex: From discovery to a cancer therapeutic target. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[47]  Z. Duan,et al.  PTEN in osteosarcoma: Recent advances and the therapeutic potential. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[48]  Shuanying Yang,et al.  Long non-coding RNA LINC01116 is overexpressed in lung adenocarcinoma and promotes tumor proliferation and metastasis. , 2020, American journal of translational research.

[49]  P. Dickman,et al.  Cancer survival statistics for patients and healthcare professionals – a tutorial of real‐world data analysis , 2020, Journal of internal medicine.

[50]  Shun-Fa Yang,et al.  New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma. , 2020, Pharmacology & therapeutics.

[51]  C. Bettegowda,et al.  The long non-coding RNA lnc-HLX-2-7 is oncogenic in group 3 medulloblastomas , 2020, bioRxiv.

[52]  Fei Wu,et al.  LINC01116 promotes tumor proliferation and neutrophil recruitment via DDX5-mediated regulation of IL-1β in glioma cell , 2020, Cell Death & Disease.

[53]  C. Earle,et al.  Development and Validation of a Prognostic Survival Model With Patient-Reported Outcomes for Patients With Cancer , 2020, JAMA network open.

[54]  G. Sauter,et al.  Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms , 2020, Cellular Oncology.

[55]  C. D. Dela Cruz,et al.  Lung Cancer 2020: Epidemiology, Etiology, and Prevention. , 2020, Clinics in chest medicine.

[56]  D. Ransohoff,et al.  Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies. , 2020, Gastroenterology.

[57]  Y. Assaraf,et al.  Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs. , 2020, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[58]  S. Yeh,et al.  Androgen receptor‐regulated circFNTA activates KRAS signaling to promote bladder cancer invasion , 2020, EMBO reports.

[59]  X. Hou,et al.  LINC01116 promotes the proliferation and inhibits the apoptosis of gastric cancer cells. , 2020, European review for medical and pharmacological sciences.

[60]  D. Forman,et al.  Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035 , 2020, Gut.

[61]  Tao Yu,et al.  TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2 , 2020, Molecular Cancer.

[62]  Jeremy A. Schofield,et al.  p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis. , 2020, Molecular cell.

[63]  A. Goel,et al.  Epigenetics of colorectal cancer: biomarker and therapeutic potential , 2020, Nature Reviews Gastroenterology & Hepatology.

[64]  Subash C. Gupta,et al.  Long non-coding RNAs and nuclear factor-B crosstalk in cancer and other human diseases. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[65]  Zhaojian Gong,et al.  Knockdown of LINC01116 inhibits cell migration and invasion in head and neck squamous cell carcinoma through epithelial‐mesenchymal transition pathway , 2020, Journal of cellular biochemistry.

[66]  Tianxin Lin,et al.  Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer. , 2019, The Journal of clinical investigation.

[67]  Binbin Lu,et al.  Long Noncoding RNA LINC01116 Contributes to Gefitinib Resistance in Non-small Cell Lung Cancer through Regulating IFI44 , 2019, Molecular therapy. Nucleic acids.

[68]  H. Xing,et al.  LINC01116 accelerates nasopharyngeal carcinoma progression based on its enhancement on MYC transcription activity , 2019, Cancer medicine.

[69]  C. Collins,et al.  The evolution of long noncoding RNA acceptance in prostate cancer initiation and progression, and its clinical utility in disease management. , 2019, European urology.

[70]  Jianjun Zhang,et al.  LncRNA LINC01116 Promotes Cancer Cell Proliferation, Migration And Invasion In Gastric Cancer By Positively Interacting With lncRNA CASC11 , 2019, OncoTargets and therapy.

[71]  Jun Lu,et al.  Up-regulated long non-coding RNA DUXAP8 promotes cell growth through repressing Krüppel-like factor 2 expression in human hepatocellular carcinoma , 2019, OncoTargets and therapy.

[72]  W. Hu,et al.  LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2. , 2019, European review for medical and pharmacological sciences.

[73]  Q. Tao,et al.  Silencing of LINC01116 suppresses the development of oral squamous cell carcinoma by up-regulating microRNA-136 to inhibit FN1 , 2019, Cancer management and research.

[74]  Zemin Zhang,et al.  GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis , 2019, Nucleic Acids Res..

[75]  Runsheng Chen,et al.  Long noncoding RNA AVAN promotes antiviral innate immunity by interacting with TRIM25 and enhancing the transcription of FOXO3a , 2019, bioRxiv.

[76]  Jinlan Jiang,et al.  Corrigendum to "LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway" [Biomed. Pharmacother. 107 (2018) 270-282]. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[77]  Lingli Chen,et al.  Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer , 2019, Gut.

[78]  Jinlan Jiang,et al.  LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[79]  Lan-Zeng Wang,et al.  LINC01116 promotes the progression of epithelial ovarian cancer via regulating cell apoptosis. , 2018, European review for medical and pharmacological sciences.

[80]  E. Zhang,et al.  Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non–small cell lung cancer cell proliferation by epigenetically repressing p21 expression , 2018, Molecular cancer.

[81]  Haoyang Hu,et al.  LncRNA LINC01116 competes with miR-145 for the regulation of ESR1 expression in breast cancer. , 2018, European review for medical and pharmacological sciences.

[82]  Jana Hertel,et al.  Non-Coding RNAs , 2008, Cellular Oncology : the Official Journal of the International Society for Cellular Oncology.

[83]  W. Guo,et al.  MiR‐93‐5p inhibits the EMT of breast cancer cells via targeting MKL‐1 and STAT3 , 2017, Experimental cell research.

[84]  Yabing Chen,et al.  The AS‐RBM15 lncRNA enhances RBM15 protein translation during megakaryocyte differentiation , 2016, EMBO reports.

[85]  G. Levy,et al.  Expression of macrophage procoagulant activity in murine systemic lupus erythematosus. , 1986, The Journal of clinical investigation.

[86]  W. Wang,et al.  Erratum: Long non-coding RNA LINC01116 is overexpressed in lung adenocarcinoma and promotes tumor proliferation and metastasis. , 2021, American journal of translational research.

[87]  Wanhong Zhang,et al.  Knocking down LINC01116 can inhibit the regulation of TGF-β through miR-774-5p axis and inhibit the occurrence and development of glioma. , 2021, American journal of translational research.

[88]  Jongchan Kim,et al.  Long noncoding RNA , 2019 .

[89]  R. Petersen,et al.  Targeting mitosis exit: A brake for cancer cell proliferation. , 2019, Biochimica et biophysica acta. Reviews on cancer.

[90]  Q. Tao,et al.  Silencing of LINC01116 suppresses the development of oral squamous cell carcinoma by up-regulating microRNA-136 to inhibit FN1 , 2019, Cancer management and research.

[91]  L. Ferguson,et al.  Role of gut microbiota in , 2009 .